GeneQuine wins Merck’s 2016 European Emerging Biotech Grant Program [ 15 Dec 2016 ]

The Emerging Biotech Grant Program, sponsored by Merck KGaA, helps upcoming biotech companies with financial and research support.

More


GeneQuine to Present at Cell Therapy Manufacturing & Gene Therapy Congress (November 29 - 30, 2016, Amsterdam) [ 23 Nov 2016 ]

GeneQuine's CEO Kilian Guse will present at the Cell Therapy Manufacturing & Gene Therapy Congress on November 29. Dr. Guse will showcase GeneQuine's novel gene therapy platform and highlight data from the lead osteoarthritis development program.

More


GeneQuine to Present at Labiotech Refresh Conference in Paris, November 24th 2016 [ 17 Nov 2016 ]

Labiotech Refresh is Europe's most refreshing Biotech conference, showcasing the industry’s trends in a dynamic and modern way.

More


BioPharm Insight publishes article on GeneQuine [ 10 Nov 2016 ]

GeneQuine's CEO Kilian Guse was interviewed by BioPharm regarding company's technology platform, pipeline and upcoming financing.

More


GeneQuine to Present at Bio Europe Partnering Conference (November 7-9, 2016, Cologne, Germany) [ 03 Nov 2016 ]

GeneQuine's CEO Kilian Guse will present at the Bio Europe Partnering Conference on Nov 9 at 9:30 AM (conference room A, level 0). Dr. Guse will introduce GeneQuine's novel gene therapy platform and highlight data from the lead osteoarthritis development program.

More


GeneQuine’s CEO Kilian Guse to Discuss Advances in Cell and Gene Therapy in Panel Discussion at the Sachs 16th Annual Biotech in Europe Forum, 27 - 28 September 2016, Basel [ 21 Sep 2016 ]

Kilian Guse will discuss advances in cell and gene therapies with other leaders in the field and present GeneQuine’s development programs.

More


GeneQuine to Attend Phacilitate Cell & Gene Therapy Europe Conference, 21-22 September, Berlin [ 13 Sep 2016 ]

GeneQuine Biotherapeutics, a company focused on the development of a novel gene therapy platform, will attend the Phacilitate Cell & Gene Therapy Europe conference held in Berlin.

More


|transkript publishes article on GeneQuine [ 02 Jun 2016 ]

GeneQuine was featured in |transkript, a leading life science magazine in the German-speaking region.

More


GeneQuine’s CEO Kilian Guse to participate in Gene Therapy Panel Discussion at Labiotech Refresh Conference (May 24, 2016, Berlin) [ 18 May 2016 ]

Kilian Guse will discuss the current state and the future of gene therapy at Labiotech Refresh Conference on a panel with other leaders in the field.

More


GeneQuine’s CEO Dr. Kilian Guse to Present at 12min.MED-Life Science (March 17, 2016, University Medical Center Hamburg-Eppendorf) [ 07 Mar 2016 ]

GeneQuine Biotherapeutics, developing gene therapy for joint diseases, will present at 12min.MED-Life Science.

More


Meet us at the European Animal Health Investment Forum 2016 (February 10 - 11, 2016, London) [ 27 Jan 2016 ]

GeneQuine Biotherapeutics, developing gene therapy for joint diseases, will attend the European Animal Health Investment Forum held in London.

More


Sponsor Fee Waiver for FY 2016 Granted by FDA [ 18 Jan 2016 ]

FDA grants GeneQuine Biotherapeutics a sponsor fee waiver under the significant barrier to innovation provision of ADUFA (Animal Drug User Fee Act) for FY 2016

More